4immune Therapeutics
Pamela Layton 4immune Chief Operating Officer
Dr. Wilson Wong

Wilson Wong, Ph.D.,  Chief Technical Officer


Dr. Wilson Wong is an Associate Professor in the Department of Biomedical Engineering at Boston University. He is also a core member of the Biological Design Center.

 

The overarching goal of Wilson’s research for the past decade has been to develop ways to control mammalian cell functions through engineering, biological network design, molecular biology, and chemical biology for medical applications, such as CAR T cell therapy. His work can be broadly characterized into four different levels of regulation: receptor signaling, post-transcription, transcription, and DNA. These tools are developed in immune cells and other tissues for cancer therapeutics, Type 1 Diabetes treatment, or diagnostics applications. 

 

Wilson joined Boston University in 2012. His work has been recognized by various awards, such as the Allen Distinguished Investigator Award, ACS Synthetic Biology Young Investigator Award, BU College of Engineering Early Career Research Excellence Award, NSF CAREER Award, and the NIH Director’s New Innovator Award. Wilson is also a scientific co-founder of Senti Biosciences.

 

Wilson holds a B.S. in chemical engineering from UC Berkeley and a Ph.D. in chemical engineering from UC Los Angeles. At UCLA, he studied synthetic biology and metabolic engineering in bacteria under the guidance of Professor James Liao. He then conducted postdoctoral research in Professor Wendell Lim’s laboratory at UCSF, in collaboration with Profess Arthur Weiss, on engineering human immune cells.

Share by: